Detailed Information

Cited 8 time in webofscience Cited 8 time in scopus
Metadata Downloads

Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization

Full metadata record
DC FieldValueLanguage
dc.contributor.authorKim, Jeong Han-
dc.contributor.authorKim, Ji Hoon-
dc.contributor.authorChoi, Jong Hwan-
dc.contributor.authorKim, Chung Ho-
dc.contributor.authorJung, Young Kul-
dc.contributor.authorYim, Hyung Joon-
dc.contributor.authorYeon, Jong Eun-
dc.contributor.authorPark, Jong-Jae-
dc.contributor.authorKim, Jae Seon-
dc.contributor.authorBak, Young-Tae-
dc.contributor.authorByun, Kwan Soo-
dc.date.available2020-11-03T09:45:32Z-
dc.date.issued2009-07-
dc.identifier.issn0036-5521-
dc.identifier.issn1502-7708-
dc.identifier.urihttps://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/16581-
dc.description.abstractObjective. The aim of this study was to evaluate the prognostic value of the model for end-stage liver disease (MELD) and its modified forms, and to compare these scoring systems with other staging systems for hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE). Material and methods. A total of 325 patients who underwent TACE for the initial treatment of HCC between January 2000 and May 2007 were enrolled in the study. Before TACE was carried out, MELD, MELD-Na, Child-Pugh score, Okuda stage, CLIP score, JIS score, BCLC stage, and UICC stage were checked. After one month, ▵MELD and ▵MELD-Na were calculated. Results. Mean MELD/MELD-Na/▵MELD/▵MELD-Na scores were 7.5±3.7, 8.0±4.7, −0.2±3.5 and 0.04±4.5, respectively. MELD (p=0.009) and MELD-Na (p=0.017) significantly correlated with survival, but ▵MELD and ▵MELD-Na did not (p >0.05). The Child-Pugh score and other staging systems correlated significantly with survival (p <0.05). The AUROC values for 3, 12, and 36 months’ survival were 0.633, 0.545, and 0.615 for MELD; 0.655, 0.555, and 0.612 for MELD-Na; 0.639, 0.616, and 0.691 for Child-Pugh score; 0.714, 0.662, and 0.717 for the Okuda score; 0.837, 0.86, and 0.792 for the CLIP score; 0.859, 0.814, and 0.808 for the JIS score; 0.846, 0.833, and 0.749 for BCLC stage; and 0.878, 0.812, and 0.735 for UICC stage, respectively. Conclusions. MELD and MELD-Na showed good correlations with survival, especially for patients with early-stage disease. However, these were not superior to those of other staging systems or Child-Pugh score. These parameters should only be used as supportive data.-
dc.format.extent12-
dc.language영어-
dc.language.isoENG-
dc.publisherTaylor & Francis-
dc.titleValue of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization-
dc.typeArticle-
dc.publisher.location영국-
dc.identifier.doi10.1080/00365520802530838-
dc.identifier.scopusid2-s2.0-61649086979-
dc.identifier.wosid000263444000015-
dc.identifier.bibliographicCitationScandinavian Journal of Gastroenterology, v.44, no.3, pp 346 - 357-
dc.citation.titleScandinavian Journal of Gastroenterology-
dc.citation.volume44-
dc.citation.number3-
dc.citation.startPage346-
dc.citation.endPage357-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaGastroenterology & Hepatology-
dc.relation.journalWebOfScienceCategoryGastroenterology & Hepatology-
dc.subject.keywordPlusSERUM SODIUM-
dc.subject.keywordPlusARTERIAL CHEMOEMBOLIZATION-
dc.subject.keywordPlusHEPATORENAL-SYNDROME-
dc.subject.keywordPlusNATURAL-HISTORY-
dc.subject.keywordPlusMELD SCORE-
dc.subject.keywordPlusCIRRHOSIS-
dc.subject.keywordPlusMORTALITY-
dc.subject.keywordPlusTRANSPLANTATION-
dc.subject.keywordPlusHYPONATREMIA-
dc.subject.keywordPlusPROGNOSIS-
dc.subject.keywordAuthorHCC-
dc.subject.keywordAuthorMELD-
dc.subject.keywordAuthorsurvival rate-
dc.subject.keywordAuthorTACE-
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Bak, Young Tae photo

Bak, Young Tae
Guro Hospital (Department of Gastroenterology and Hepatology, Guro Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE